• By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.
OK
Advertisement
Pseudo lymph node might improve CAR-T British Society for Haematology13:34T-Cells Health
Earlier today
Yesterday
CAR-T therapy achieves lupus remission breakthrough Biopharma Reporter15:51 18-Jun-24
In the last 7 days
Immix Biopharma to Present at the Stifel 2024 Cell Therapy Forum GlobeNewswire (Press Release)14:35 17-Jun-24
Pseudo lymph node might improve CAR-T British Society for Haematology13:34 17-Jun-24
Low risk of cancer after car-T therapy Stanford University10:04 17-Jun-24
Case Study Reveals Important New Details About Rare Second Cancers Related to CAR-T Therapy Georgetown University Medical Center (Press Release)22:00 12-Jun-24
In the last month
Role of neutrophils in CAR-T complication studied British Society for Haematology10:25 10-Jun-24
Patient receives car-T therapy The Times of India00:29 8-Jun-24
How to monitor cell health in real-time 3 Quarks Daily13:41 29-May-24
Progressing personalised cell therapies in oncology European Pharmaceutical Review10:04 23-May-24
view more headlines
19 Jun 06:59

About our CAR-T news

Latest news on CAR-T (Chimeric Antigen Receptor T-cell) therapy, a type of cancer treatment that involves modifying patients' T-cells to recognize and attack cancer cells. In this therapy, T-cells are collected from the patient, engineered in a lab to express a specific receptor that binds to a protein on cancer cells, and then infused back into the patient to fight the cancer. CAR-T therapies have shown promise in treating certain types of blood cancers, like lymphoma and leukemia.


Publication filters

Headline Density

Sorry, no headlines or news topics were found. Please try different keywords.